Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

DOBUTAMINE

CompanyHospira, Inc. (DUNS: 141588017)

Effective Date

November 26, 2019

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Dobutamine(12.5 mg in 1 mL)

Manufacturing Establishments (1)

Labeler

Hospira, Inc.

DUNS Number

030606222

Products (1)

DOBUTAMINE

NDC Product Code

0409-2344

Application Number

ANDA074086

Marketing Category

ANDA (C73584)

Route of Administration

INTRAVENOUS

Effective Date

November 26, 2019

Ingredients

DobutamineActive

Code: 0WR771DJXVClass: ACTIMQuantity: 12.5 mg in 1 mL

SODIUM METABISULFITEInactive

Code: 4VON5FNS3CClass: IACTQuantity: 0.2 mg in 1 mL

HYDROCHLORIC ACIDInactive

Code: QTT17582CBClass: IACT

SODIUM HYDROXIDEInactive

Code: 55X04QC32IClass: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy